Stanford University
Showing 21,521-21,540 of 37,003 Results
-
Despina Milathianaki
Development Manager, SLAC National Accelerator Laboratory
BioDespina is the Director of the Office of Technology Transfer and Strategic Partnerships in the organization of the SLAC Deputy Director for Science and Technology. She and her team help accelerate the translation of cutting-edge research into transformative technologies and solutions through the development and execution of tech transfer programs and strategic partnerships with industry, academia, and government sponsors. Before her current role, Despina served as senior director for Department of Energy partnerships in the quantum computing industry establishing important R&D programs between the private sector and the national labs. Prior roles in the private sector included management consulting for Accenture UK and engineering for a Silicon valley startup. Despina first joined SLAC in 2010 as a staff scientist at the Linac Coherent Light Source investigating materials science at extreme conditions. She later transitioned to strategic planning where she served as the director of strategic planning and investment for SLAC. Despina holds a Bachelor's in Physics from Imperial College London and a Master’s in Electrical Engineering from the University of Michigan. She completed her PhD in High Energy Density Physics at the University of Texas at Austin, conducting research at Lawrence Livermore National Laboratory.
-
Christina Milcarek
Executive Administrator, Med/Stanford Center for Clinical Research
Current Role at StanfordProviding executive support to:
Dr. Kenneth Mahaffey, Founding Director, Stanford Center for Clinical Research (SCCR) -
Paul Milgrom
Shirley R. and Leonard W. Ely, Jr. Professor in the School of Humanities and Sciences, Professor of Economics, Senior Fellow at SIEPR and Professor, by courtesy, of Economics at the GSB and of Management Science and Engineering
BioPaul Milgrom is the Shirley and Leonard Ely professor of Humanities and Sciences in the Department of Economics at Stanford University and professor, by courtesy, in the Stanford Graduate School of Business and in the Department of Management Sciences and Engineering. Born in Detroit, Michigan on April 20, 1948, he is a member of both the National Academy of Sciences and the American Academy of Arts and Sciences and a winner of the 2008 Nemmers Prize in Economics, the 2012 BBVA Frontiers of Knowledge award, the 2017 CME-MSRI prize for Innovative Quantitative Applications, and the 2018 Carty Award for the Advancement of Science.
Milgrom is known for his work on innovative resource allocation methods, particularly in radio spectrum. He is coinventor of the simultaneous multiple round auction and the combinatorial clock auction. He also led the design team for the FCC's 2017 incentive auction, which reallocated spectrum from television broadcast to mobile broadband.
According to his BBVA Award citation: “Paul Milgrom has made seminal contributions to an unusually wide range of fields of economics including auctions, market design, contracts and incentives, industrial economics, economics of organizations, finance, and game theory.” As counted by Google Scholar, Milgrom’s books and articles have received more than 80,000 citations.
Finally, Milgrom has been a successful adviser of graduate students, winning the 2017 H&S Dean's award for Excellence in Graduate Education. -
Amin Milki, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Current Research and Scholarly InterestsInfertility
Assisted Reproductive Technologies Microsurgery and Endoscopic Surgery. -
Carlos Milla
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary, Allergy and Critical Care Medicine)
Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.
